title: Optimal use of contrast echo in daily practice: what do we need?
abstract: With new low power imaging and contrast application technology, it seems possible for the first time to develop a protocol that combines acquisition of both function and perfusion data using a simple modality. For this purpose a European network has been created and this group is currently developing a protocol using a commercially available ultrasound scanner and the infusion of the echocontrast agent SonoVue (Bracco). This study describes the technical developments that will promote a comprehensive clinical contrast protocol for assessment of patients with ischemic heart disease.
authors.affiliation: John Radcliffe Hospital, Cardiac Clinical Center, Headley Way, Oxford OX3 9DU, United Kingdom. harald.becher@orh.nhs.uk
authors.forename: Harald
authors.initials: H
authors.lastname: Becher
authors.forename: Jonathan
authors.initials: J
authors.lastname: Timperley
mesh_terms: D003287:Contrast Media / Q000008:administration & dosage; D003327:Coronary Disease / Q000000981:diagnostic imaging*; D004452:Echocardiography / Q000295:instrumentation / Q000379:methods*; D005060:Europe; D006801:Humans; D007089:Image Enhancement / Q000379:methods; D007260:Infusion Pumps; D010743:Phospholipids / Q000008:administration & dosage; D010818:Practice Patterns, Physicians'; D013459:Sulfur Hexafluoride / Q000008:administration & dosage
chemical_list: D003287:Contrast Media; D010743:Phospholipids; C420843:contrast agent BR1; D013459:Sulfur Hexafluoride